Chemplast Sanmar Ltd
It is a major manufacturer of Speciality Chemicals such as Specialty Paste PVC resin and Custom Manufactured Chemicals for agro-chemical, pharmaceutical and fine chemicals sector. The company also produces other chemicals such as Caustic Soda, Chlorochemicals, Hydrogen Peroxide, Refrigerant gas and Industrial Salt. The manufacturing facilities are located at Mettur, Berigai and Vedaranyam in Tamil Nadu and Karaikal in the Union Territory of Puducherry.
- Market Cap ₹ 7,752 Cr.
- Current Price ₹ 490
- High / Low ₹ 634 / 403
- Stock P/E
- Book Value ₹ 245
- Dividend Yield 0.00 %
- ROCE -3.27 %
- ROE -3.13 %
- Face Value ₹ 5.00
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.74% over past five years.
- Company has a low return on equity of 4.00% over last 3 years.
- Earnings include an other income of Rs.18.3 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 500 BSE 400 MidSmallCap Index BSE 250 SmallCap Index Nifty 500 BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,243 | 2,645 | 2,643 | 2,493 | 2,903 | 1,106 | 1,253 | 1,259 | 1,289 | 2,012 | 2,197 | 1,656 | 2,031 | |
2,000 | 2,428 | 2,485 | 2,143 | 2,424 | 848 | 936 | 945 | 898 | 1,385 | 1,891 | 1,714 | 1,999 | |
Operating Profit | 243 | 217 | 158 | 350 | 479 | 259 | 317 | 314 | 391 | 628 | 306 | -58 | 33 |
OPM % | 11% | 8% | 6% | 14% | 17% | 23% | 25% | 25% | 30% | 31% | 14% | -4% | 2% |
13 | 32 | 27 | 20 | -20 | 114 | 32 | 8 | -10 | 33 | -24 | 42 | 18 | |
Interest | 150 | 167 | 163 | 162 | 73 | 37 | 47 | 95 | 254 | 136 | 23 | 33 | 63 |
Depreciation | 94 | 91 | 57 | 65 | 69 | 57 | 55 | 87 | 88 | 91 | 92 | 107 | 128 |
Profit before tax | 11 | -9 | -35 | 143 | 318 | 278 | 248 | 139 | 40 | 434 | 167 | -156 | -140 |
Tax % | -4% | -17% | -27% | 43% | 53% | 34% | 24% | 29% | -9% | 12% | 13% | -33% | |
12 | -8 | -26 | 82 | 150 | 183 | 187 | 99 | 44 | 379 | 146 | -104 | -100 | |
EPS in Rs | 0.15 | -49,187.50 | -159,375.00 | 10.24 | 18.78 | 22.93 | 23.40 | 14.73 | 3.25 | 24.00 | 9.21 | -6.57 | -6.34 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
Compounded Sales Growth | |
---|---|
10 Years: | -5% |
5 Years: | 6% |
3 Years: | 9% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -297% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -7% |
1 Year: | 10% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 4% |
3 Years: | 4% |
Last Year: | -3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 80 | 80 | 80 | 80 | 80 | 67 | 67 | 67 | 67 | 79 | 79 | 79 | 79 |
Reserves | 179 | 172 | 144 | 226 | 237 | 652 | 2,449 | 1,910 | 1,954 | 3,718 | 3,865 | 3,761 | 3,796 |
763 | 340 | 684 | 731 | 427 | 210 | 253 | 1,289 | 1,228 | 14 | 218 | 656 | 734 | |
895 | 1,265 | 1,135 | 916 | 1,528 | 1,820 | 1,051 | 941 | 1,035 | 1,142 | 1,332 | 1,334 | 1,276 | |
Total Liabilities | 1,918 | 1,857 | 2,043 | 1,954 | 2,272 | 2,750 | 3,820 | 4,206 | 4,284 | 4,954 | 5,494 | 5,830 | 5,885 |
1,224 | 1,206 | 1,154 | 1,107 | 1,067 | 625 | 2,087 | 2,175 | 2,103 | 2,233 | 2,200 | 2,929 | 2,932 | |
CWIP | 61 | 7 | 11 | 9 | 6 | 82 | 117 | 8 | 25 | 27 | 388 | 186 | 246 |
Investments | 1 | 1 | 1 | 243 | 608 | 938 | 1,199 | 1,556 | 1,556 | 1,556 | 1,556 | 1,556 | 1,556 |
632 | 644 | 877 | 595 | 592 | 1,106 | 417 | 467 | 600 | 1,138 | 1,351 | 1,160 | 1,152 | |
Total Assets | 1,918 | 1,857 | 2,043 | 1,954 | 2,272 | 2,750 | 3,820 | 4,206 | 4,284 | 4,954 | 5,494 | 5,830 | 5,885 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
291 | 575 | 113 | 176 | 642 | 448 | 232 | 166 | 411 | 430 | 271 | -98 | |
17 | -14 | 5 | -247 | -388 | -407 | -311 | -438 | -80 | -51 | -286 | -537 | |
-241 | -589 | 178 | -113 | -350 | 24 | -1 | 298 | -333 | -96 | 171 | 406 | |
Net Cash Flow | 67 | -27 | 296 | -183 | -96 | 64 | -80 | 26 | -1 | 283 | 155 | -230 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 15 | 19 | 15 | 11 | 9 | 18 | 19 | 14 | 19 | 33 | 43 | 40 |
Inventory Days | 48 | 41 | 32 | 41 | 68 | 135 | 183 | 158 | 203 | 180 | 147 | 164 |
Days Payable | 205 | 243 | 203 | 183 | 220 | 197 | 200 | 187 | 265 | 201 | 212 | 256 |
Cash Conversion Cycle | -141 | -183 | -156 | -131 | -143 | -44 | 2 | -16 | -43 | 13 | -23 | -52 |
Working Capital Days | -67 | -101 | -96 | -76 | -115 | -36 | -45 | -5 | -11 | 15 | -1 | 3 |
ROCE % | 15% | 20% | 16% | 31% | 49% | 38% | 15% | 8% | 9% | 16% | 6% | -3% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
13 Nov - Transcripts of earnings call held on Nov 6 , 2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 Nov - Audio recording of earnings call published.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Nov
-
Announcement under Regulation 30 (LODR)-Investor Presentation
5 Nov - Investor presentation on Q2 FY '25 performance highlights.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
5 Nov - Q2 FY '25 earnings release and financial highlights.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from web
-
Financial Year 2020
from web
-
Financial Year 2019
from web
-
Financial Year 2018
from web
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Oct 2021TranscriptNotesPPT
History
Chemplast Sanmar Ltd was delisted in 2012 (at Mcap of 1,189 Cr.) following losses faced during the global financial crisis of 2008-09. It was relisted in 2021 at a Mcap of 8,553 Cr. [1]